Structural commentary
Cyclohexenone is a versatile intermediate used in the synthesis of a variety of chemical products such as pharmaceuticals and fragrances. Cyclohexenone and cyclohexenone derivatives are known for anti-inflammatory and analgesic activities (Kalluraya & Rahiman, 2003) . ,-Unsaturated carbonyl compounds have shown various biological activities such as antioxidant (Suksamrarn et al., 2003) , antitumor (Kumar et al., 2003) , anticancer (Modzelewska et al., 2006) and antimalarial (Ferrer et al., 2009 ). In addition, chalcones are widely used in cosmetic compositions (Forestier et al., 1989; Podraze, 1991) and in applications of dyes (Asiri, 2003) . Cyclohexenone derivatives are well known lead molecules for the treatment of inflammation and autoimmune diseases (Tanaka et al., 1997) . Apart from being biologically important compounds, chalcone derivatives show nonlinear optical (NLO) properties with excellent blue light transmittance and good crystallizability (Shettigar et al., 2006) . In this context, herein we report the synthesis and crystal structure of the title compound.
The title compound crystallized with two molecules (A and B) in the asymmetric unit (Fig. 1) . The benzyloxyphenyl and ISSN 2056-9890 the methoxyphenyl rings are linked with a cyclohexene ring. The C25-O1 and C25A-O1A bond lengths of 1.228 (3) and 1.224 (3) Å , respectively, indicate double-bond character. In both molecules, the C-O bond lengths are in the range 1.362 (3)-1.414 (4) Å and represent single-bond character. In molecule A, the torsion angles C5-C4-C7-C8 = 69.2 (4) and C24-C9-C10-C11 = À16.0 (4) show that the benzyloxyphenyl and methoxyphenyl groups have a +sc and -sp orientation with respect to the cyclohexene moiety. The arrangement in molecule B is slightly different, with torsion angles C5A-C4A-C7A-C8A = 111. 5 (3) and C24A-C9A-C10A- C11A = 20.8 (4) . The cyclohexene ring in both molecules adopts an envelope conformation with atoms C7 and C7A as the flaps in molecules A and B, respectively.
The crystal packing (Fig. 2) is stabilized by C-HÁ Á Á interactions (Table 1) .
Synthesis and crystallization
(2E)-3-(4-Benzyloxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one was synthesized following the literature procedure of Ezhilarasi et al. (2014) . The synthesis of the title compound was carried out by following the reported procedure of Fun et al. (2012) . In a 100 ml round-bottomeded flask, (2E)-3-(4-benzyloxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one (0.01 mol) and ethyl methyl ketone (0.01 mol) were refluxed in absolute alcohol (50 ml) in the presence of 10% sodium hydroxide solution (10 ml) for 1 h in an oil bath. The reaction The molecular structure of the two independent molecules of the title compound, showing the atom labelling. Displacement ellipsoids are drawn at the 30% probability level. Table 1 Hydrogen-bond geometry (Å , ).
Cg3 and Cg8 are the centroids of rings C10-C15 and C10A-C15A, respectively. Figure 2
A view along the b axis of the crystal packing of the title compound. 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The H atoms were positioned geometrically and treated as riding atoms, with C-H = 0.93-0.98 Å , and with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C) for other H atoms. 
Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
